The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

Asymmetry in clinical features of drug-induced parkinsonism

Published Online:https://doi.org/10.1176/jnp.2.1.64

In clinical practice, distinguishing drug-induced parkinsonism from Parkinson's disease may be difficult. Asymmetry is generally not felt to be common in drug-induced parkinsonism. The authors investigated asymmetry of signs and symptoms in 20 patients with drug-induced parkinsonism. Tremor was identified in seven patients, slowness in five, and mixed symptoms in eight. A notable asymmetry of signs was seen in six patients. As in Parkinson's disease, subgroups seem to exist within the group of patients with drug-induced parkinsonism, and an asymmetry of signs and symptoms is not uncommon.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.